Article

Abiraterone acetate.

Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas 77030, USA. ; .
dressNature Reviews Drug Discovery (Impact Factor: 33.08). 01/2011; 10(8):573-4. DOI: 10.1038/nrd3516
Source: PubMed

ABSTRACT In April 2011, abiraterone acetate (Zytiga; Centocor Ortho Biotech), in combination with prednisone, was approved by the US Food and Drug Administration (FDA) for the treatment of patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.

0 Bookmarks
 · 
82 Views